1 INDICATIONS & USAGE Aripiprazole oral tablets are indicated for the treatment of: • Schizophrenia - [see CLINICAL STUDIES (14
2%), EPS (up to 18
Aripiprazole comes as a tablet, a solution (liquid), an orally disintegrating tablet (tablet that dissolves quickly in the mouth) to take by mouth
The In an analysis of 13 placebo-controlled monotherapy trials in adults, primarily with schizophrenia or another indication, the mean change in fasting glucose in aripiprazole-treated patients (+4
The maximum dose is 20 mg per day if you weigh 50 kg (110 lbs) or more
Dose for schizophrenia
In an analysis of 13 placebo-controlled monotherapy trials in adults, primarily with schizophrenia or another disorder, the mean change in fasting glucose in aripiprazole-treated patients (+4
2 mL; Abilify MyCite® Oral tablet with a digestible sensor: 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, 30 mg; Abilify Maintena® Extended-release injectable suspension: 300 mg, 400 mg; Aristada® (aripiprazole lauroxil) Extended-release injectable suspension: 441 mg
It is used to treat certain behavior problems in patients with autism
4 mg/dL; median exposure 25 days; N=1,057) was not significantly different than in placebo-treated patients (+2
ABILIFY is an atypical antipsychotic indicated as oral formulations for the:
4 mg/dL; median exposure 25 days; N=1,057) was not significantly different than in placebo-treated patients (+2
2 mL) and
Aripiprazole was studied in adolescent patients 13 to 17 years of age with schizophrenia at daily doses of 10 mg and 30 mg
When making dose and dosing interval
In an analysis of two placebo-controlled trials in adolescents with schizophrenia (13 to 17 years) and pediatric patients with bipolar disorder (10 to 17 years), the mean change in fasting glucose in aripiprazole-treated patients (+4